Nutritional Growth Solutions (ASX:NGS) — Material Events
ASX:NGS · 14 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Nutritional Growth Solutions Hits Normalised Profitability and Becomes Debt-Free with $710K CashMedium
Nutritional Growth Solutions achieves normalised profitability, completes cost restructure, and becomes debt-free with US$710k cash
20 Apr 2026
·Quarterly Activities Report and Appendix 4C Cash Flow Statement
·80
NGS Charts Leaner Path to Growth with $2m Capital Raise and New CEOMedium
NGS reports Q4 FY25 revenue US$362k, cost cuts improve cash flow, A$2m placement secured, new CEO appointed
30 Jan 2026
·Quarterly Activities Report and Appendix 4C
·75
Nutritional Growth Solutions Secures $2M Placement to Accelerate ExpansionMedium
Nutritional Growth Solutions secures A$2M placement to fund growth initiatives
3 Nov 2025
·Capital Raising
·75
NGS Explains Quarterly Report Revisions, Affirms Financial Stability Amid ChallengesMedium
NGS clarifies quarterly report revisions, confirms financial stability and ongoing compliance
12 Aug 2025
·ASX Query Response
·75
NGS Boosts US Retail Reach with 13% Revenue Rise, Eyes Cash Flow TurnaroundMedium
NGS Q3 FY25 revenue up 13%, expands US retail footprint, raises AU$760k, targets improved cash flow
30 Oct 2025
·Quarterly Activities Report and Appendix 4C
·75
Nutritional Growth Solutions Shrinks Losses Amid Retail Expansion PushMedium
Nutritional Growth Solutions reports revenue decline, smaller loss, and key retail expansions; raises capital and exits non-core US contracts
29 Aug 2025
·Appendix 4D
·70
NGS Corrects Q2 Financials Amid Major US Retail ExpansionMedium
NGS revises Q2 FY25 financials; expands retail footprint with CVS and Walmart; capital raise underway
5 Aug 2025
·Quarterly Activities Report and Appendix 4C Cashflow Statement Correction
·70
Nutritional Growth Solutions Raises $760K to Fuel Retail ExpansionMedium
Nutritional Growth Solutions raises $760K via discounted share placement for retail expansion
5 Aug 2025
·Capital Raising
·70
NGS Nears Profitability Amid CVS Launch and Walmart ExpansionMedium
NGS Q2 FY25 revenue dips 13.6%, completes CVS rollout, expands Walmart range, improves cash flow
31 July 2025
·Quarterly Activities Report and Appendix 4C
·70
NGS Cuts US Ties, Gains $580K to Sharpen Growth FocusMedium
NGS exits non-core US agreements with Elixinol, gains USD 580K financial relief
27 Aug 2025
·Settlement Agreement Announcement
·65
NGS Trading Resumes After Capital Raising Announcement Sparks InterestMedium
NGS trading suspension lifted after capital raising announcement
5 Aug 2025
·Reinstatement to Quotation
·60
Nutritional Growth Solutions Names Interim CEO Amid Leadership ChangeMedium
Nutritional Growth Solutions CEO Stephen Turner to depart; Andrew Grover appointed Interim CEO
24 Dec 2025
·Executive Change Announcement
·60
Why Nutritional Growth Solutions Has Halted Trading Ahead of Capital RaiseMedium
Nutritional Growth Solutions requests voluntary suspension pending capital raising announcement
5 Aug 2025
·Suspension from Quotation
·50
NGS Director Manik Pujara Takes Interim CEO and CFO Roles Amid Corporate Opportunity HuntMedium
NGS appoints Director Manik Pujara as interim CEO and CFO; Andrew Grover steps down as interim CEO
16 Apr 2026
·Board and Executive Update
·50
No articles in this tier for the last 12 months.